When should you take cholesterol medicine
Pro Research Analysisby 
Searched over 200M research papers
When to Take Cholesterol Medicine: Key Considerations
Importance of Cholesterol Management
Managing cholesterol levels is crucial for preventing atherosclerotic cardiovascular disease (CVD). High cholesterol, particularly elevated low-density lipoprotein (LDL) cholesterol, is a significant risk factor for CVD. The use of cholesterol-lowering medications, especially statins, has been extensively supported by evidence to reduce lipid disorders and subsequent CVD events.
Statins: The Primary Cholesterol-Lowering Medication
Statins are the most commonly prescribed cholesterol-lowering medications. They work by inhibiting the enzyme HMG-CoA reductase, which plays a central role in the production of cholesterol in the liver. Statins have been shown to reduce LDL cholesterol levels significantly, with reductions ranging from 25% to 61% depending on the dosage. The 2013 cholesterol treatment guidelines recommend statin therapy based on LDL cholesterol levels and overall CVD risk.
When to Start Taking Statins
- Age and Health Insurance: Adults aged 40 and over are more likely to be prescribed statins, especially if they have health insurance or prescription medication coverage.
- Diagnosed Conditions: Statins are particularly recommended for individuals with diagnosed cardiovascular disease, diabetes, or hypercholesterolemia. Approximately 71% of adults with diagnosed CVD, 63% with diabetes, and 54% with hypercholesterolemia reported taking statins.
- High LDL Cholesterol: Individuals with high LDL cholesterol levels, particularly those with familial hypercholesterolemia, are prime candidates for statin therapy. In cases of familial hypercholesterolemia, medications like inclisiran, which significantly reduce LDL cholesterol levels, may also be considered.
Alternative and Adjunctive Therapies
For patients who do not achieve sufficient cholesterol reduction with statins alone, or who experience side effects, additional medications may be prescribed. These include:
- Inclisiran: A small interfering RNA that inhibits hepatic synthesis of PCSK9, leading to robust reductions in LDL cholesterol levels with an infrequent dosing regimen.
- Combination Therapy: Some patients may benefit from a combination of statins and nonstatin medications to achieve desired cholesterol levels.
Conclusion
Cholesterol-lowering medications, particularly statins, are essential for managing high cholesterol and reducing the risk of cardiovascular disease. The decision to start these medications should be based on age, existing health conditions, and LDL cholesterol levels. For those with familial hypercholesterolemia or those who do not respond adequately to statins, alternative treatments like inclisiran may be effective. Always consult with a healthcare provider to determine the most appropriate treatment plan for your specific needs.
Sources and full results
Most relevant research papers on this topic